The combined effect of recombinant human epidermal growth factor and erythropoietin on full-thickness wound healing in diabetic rat model

International Wound Journal

Volumn 11, Issue 4, 2014, Pages 373-378

  Hong, Joon Pio ^a   Park, Sung Woo ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Diabetes; Epidermal growth factor; Erythropoietin; Wound healing

Indexed keywords

EASYEF; EPOSIS; ERYTHROPOIETIN; KI 67 ANTIGEN; RECOMBINANT EPIDERMAL GROWTH FACTOR; UNCLASSIFIED DRUG; EPIDERMAL GROWTH FACTOR; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BANDAGE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; HISTOPATHOLOGY; HYDROCOLLOID DRESSING; IMMUNOHISTOCHEMISTRY; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; RAT; WOUND HEALING; ANIMAL; DRUG COMBINATION; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; FOLLOW UP; HUMAN; INJURIES; PATHOLOGY; SKIN; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME; WOUNDS, PENETRATING;

ANIMALS; BANDAGES, HYDROCOLLOID; DIABETES MELLITUS, EXPERIMENTAL; DRUG THERAPY, COMBINATION; EPIDERMAL GROWTH FACTOR; ERYTHROPOIETIN; FOLLOW-UP STUDIES; HUMANS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; SKIN; TREATMENT OUTCOME; WOUND HEALING; WOUNDS, PENETRATING;

EID: 84904415053     PISSN: 17424801     EISSN: 1742481X     Source Type: Journal    
DOI: 10.1111/j.1742-481X.2012.01100.x     Document Type: Article

References (23)

1. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999 ; 341: 738 - 46.
2. Greenhalgh DG. The role of growth factors in wound healing. J Trauma 1996 ; 41: 159 - 67.
3. Brown GL, Curtsinger L, Jurkiewicz MJ, Nahai F, Schultz G. Stimulation of healing of chronic wounds by epidermal growth factor. Plast Reconstr Surg 1991 ; 88: 189 - 94 ; discussion 95 - 6.
4. Tsang MW, Wong WK, Hung CS, Lai KM, Tang W, Cheung EY, Kam G, Leung L, Chan CW, Chu CM, Lam EK. Human epidermal growth factor enhances healing of diabetic foot ulcers. Diabetes Care 2003 ; 26: 1856 - 61.
5. Bennett SP, Griffiths GD, Schor AM, Leese GP, Schor SL. Growth factors in the treatment of diabetic foot ulcers. Br J Surg 2003 ; 90: 133 - 46.
6. Nanney LB. Epidermal and dermal effects of epidermal growth factor during wound repair. J Invest Dermatol 1990 ; 94: 624 - 9.
7. Brown GL, Curtsinger L 3rd, Brightwell JR, Ackerman DM, Tobin GR, Polk HC Jr, George-Nascimento C, Valenzuela P, Schultz GS. Enhancement of epidermal regeneration by biosynthetic epidermal growth factor. J Exp Med 1986 ; 163: 1319 - 24.
8. Epstein JB, Gorsky M, Guglietta A, Le N, Sonis ST. The correlation between epidermal growth factor levels in saliva and the severity of oral mucositis during oropharyngeal radiation therapy. Cancer 2000 ; 89: 2258 - 65.
9. Fisher JW. Erythropoietin: physiology and pharmacology update. Exp Biol Med (Maywood) 2003 ; 228: 1 - 14.
10. Digicaylioglu M, Lipton SA. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 2001 ; 412: 641 - 7.
11. Moon C, Krawczyk M, Ahn D, Ahmet I, Paik D, Lakatta EG, Talan MI. Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats. Proc Natl Acad Sci U S A 2003 ; 100: 11612 - 7.
12. Spandou E, Tsouchnikas I, Karkavelas G, Dounousi E, Simeonidou C, Guiba-Tziampiri O, Tsakiris D. Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model. Nephrol Dial Transplant 2006 ; 21: 330 - 6.
13. Parsa CJ, Kim J, Riel RU, Pascal LS, Thompson RB, Petrofski JA, Matsumoto A, Stamler JS, Koch WJ. Cardioprotective effects of erythropoietin in the reperfused ischemic heart: a potential role for cardiac fibroblasts. J Biol Chem 2004 ; 279: 20655 - 62.
14. Buemi M, Vaccaro M, Sturiale A, Galeano MR, Sansotta C, Cavallari V, Floccari F, D'Amico D, Torre V, Calapai G, Frisina N, Guarneri F, Vermiglio G. Recombinant human erythropoietin influences revascularization and healing in a rat model of random ischaemic flaps. Acta Derm Venereol 2002 ; 82: 411 - 7.
15. Gary Sibbald R, Woo KY. The biology of chronic foot ulcers in persons with diabetes. Diabetes Metab Res Rev 2008 ; 24 ( 1 Suppl): S25 - 30.
16. Schaffer CJ, Nanney LB. Cell biology of wound healing. Int Rev Cytol 1996 ; 169: 151 - 81.
17. Hockel M, Schlenger K, Doctrow S, Kissel T, Vaupel P. Therapeutic angiogenesis. Arch Surg 1993 ; 128: 423 - 9.
18. Jelkmann W. Biology of erythropoietin. Clin Investig 1994 ; 72 ( 6 Suppl): S3 - 10.
19. Goodnough LT, Monk TG, Andriole GL. Erythropoietin therapy. N Engl J Med 1997 ; 336: 933 - 8.
20. Alvarez Arroyo MV, Castilla MA, Gonzalez Pacheco FR, Tan D, Riesco A, Casado S, Caramelo C. Role of vascular endothelial growth factor on erythropoietin-related endothelial cell proliferation. J Am Soc Nephrol 1998 ; 9: 1998 - 2004.
21. Risau W. Mechanisms of angiogenesis. Nature 1997 ; 386: 671 - 4.
22. Zachary I. Vascular endothelial growth factor. Int J Biochem Cell Biol 1998 ; 30: 1169 - 74.
23. Choi K, Kennedy M, Kazarov A, Papadimitriou JC, Keller G. A common precursor for hematopoietic and endothelial cells. Development 1998 ; 125: 725 - 32.